Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
We urged Congress to support and co-sponsor the MORE Act (H.R. 5068). We urged Congress to oppose the Combating Xylazine Act(H.R. 1266/S. 545), Nitazene Control Act (H.R. 5415 /S. 3076), and STOP Nitazenes Act (H.R. 7970).
We urged Congress to support and co-sponsor the MORE Act (H.R. 5068). We urged Congress to support and co-sponsor the Cannabis Administration and Opportunity Act in the Senate. We urged Congress to oppose the Combating Xylazine Act(H.R. 1266/S. 545), Nitazene Control Act (H.R. 5415 /S. 3076), and STOP Nitazenes Act (H.R. 7970).
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2026 · third_quarter · Q3
We urged Congress to support and co-sponsor the MORE Act (H.R. 5068). We urged Congress to support and co-sponsor the Cannabis Administration and Opportunity Act in the Senate. We urged Congress to oppose the Combating Xylazine Act(H.R. 1266/S. 545), Nitazene Control Act (H.R. 5415 /S. 3076), and STOP Nitazenes Act (H.R. 7970).
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2026 · second_quarter · Q2
Source: Senate LDA
We urged Congress to support and co-sponsor the MORE Act (H.R. 5068). We urged Congress to support and co-sponsor the Cannabis Administration and Opportunity Act in the Senate. We urged Congress to oppose the Combating Xylazine Act(H.R. 1266/S. 545), Nitazene Control Act (H.R. 5415 /S. 3076), and STOP Nitazenes Act (H.R. 7970).
We urged Congress to support and co-sponsor the MORE Act (H.R. 5068). We urged Congress to support and co-sponsor the Cannabis Administration and Opportunity Act in the Senate. We urged Congress to oppose the Combating Xylazine Act(H.R. 1266/S. 545), Nitazene Control Act (H.R. 5415 /S. 3076), and STOP Nitazenes Act (H.R. 7970).
We urged Congress to support and co-sponsor the MORE Act (H.R. 5068). We urged Congress to support and co-sponsor the Cannabis Administration and Opportunity Act in the Senate. We urged Congress to oppose the Combating Xylazine Act(H.R. 1266/S. 545), Nitazene Control Act (H.R. 5415 /S. 3076), and STOP Nitazenes Act (H.R. 7970).
We urged Congress to support and co-sponsor the MORE Act (H.R. 5068). We urged Congress to oppose the Combating Xylazine Act(H.R. 1266/S. 545), Nitazene Control Act (H.R. 5415 /S. 3076), and STOP Nitazenes Act (H.R. 7970).
We urged Congress to support and co-sponsor the MORE Act (H.R. 5068). We urged Congress to oppose the Combating Xylazine Act(H.R. 1266/S. 545), Nitazene Control Act (H.R. 5415 /S. 3076), and STOP Nitazenes Act (H.R. 7970).
We urged Congress to support and co-sponsor the MORE Act (H.R. 5068). We urged Congress to support and co-sponsor the Cannabis Administration and Opportunity Act in the Senate. We urged Congress to oppose the Combating Xylazine Act(H.R. 1266/S. 545), Nitazene Control Act (H.R. 5415 /S. 3076), and STOP Nitazenes Act (H.R. 7970).
We urged Congress to support and co-sponsor the MORE Act (H.R. 5068). We urged Congress to support and co-sponsor the Cannabis Administration and Opportunity Act in the Senate. We urged Congress to oppose the Combating Xylazine Act(H.R. 1266/S. 545), Nitazene Control Act (H.R. 5415 /S. 3076), and STOP Nitazenes Act (H.R. 7970).
We urged Congress to support and co-sponsor the MORE Act (H.R. 5068). We urged Congress to support and co-sponsor the Cannabis Administration and Opportunity Act in the Senate. We urged Congress to oppose the Combating Xylazine Act(H.R. 1266/S. 545), Nitazene Control Act (H.R. 5415 /S. 3076), and STOP Nitazenes Act (H.R. 7970).
We urged Congress to support and co-sponsor the MORE Act (H.R. 5068). We urged Congress to support and co-sponsor the Cannabis Administration and Opportunity Act in the Senate. We urged Congress to oppose the Combating Xylazine Act(H.R. 1266/S. 545), Nitazene Control Act (H.R. 5415 /S. 3076), and STOP Nitazenes Act (H.R. 7970).
We urged Congress to support and co-sponsor the MORE Act (H.R. 5068). We urged Congress to oppose the Combating Xylazine Act(H.R. 1266/S. 545), Nitazene Control Act (H.R. 5415 /S. 3076), and STOP Nitazenes Act (H.R. 7970).
We urged Congress to support and co-sponsor the MORE Act (H.R. 5068). We urged Congress to support and co-sponsor the Cannabis Administration and Opportunity Act in the Senate. We urged Congress to oppose the Combating Xylazine Act(H.R. 1266/S. 545), Nitazene Control Act (H.R. 5415 /S. 3076), and STOP Nitazenes Act (H.R. 7970).
We urged Congress to support and co-sponsor the MORE Act (H.R. 5068). We urged Congress to oppose the Combating Xylazine Act(H.R. 1266/S. 545), Nitazene Control Act (H.R. 5415 /S. 3076), and STOP Nitazenes Act (H.R. 7970).
We urged Congress to support and co-sponsor the MORE Act (H.R. 5068). We urged Congress to support and co-sponsor the Cannabis Administration and Opportunity Act in the Senate. We urged Congress to oppose the Combating Xylazine Act(H.R. 1266/S. 545), Nitazene Control Act (H.R. 5415 /S. 3076), and STOP Nitazenes Act (H.R. 7970).
We urged Congress to support and co-sponsor the MORE Act (H.R. 5068). We urged Congress to support and co-sponsor the Cannabis Administration and Opportunity Act in the Senate. We urged Congress to oppose the Combating Xylazine Act(H.R. 1266/S. 545), Nitazene Control Act (H.R. 5415 /S. 3076), and STOP Nitazenes Act (H.R. 7970).
We urged Congress to support and co-sponsor the MORE Act (H.R. 5068). We urged Congress to support and co-sponsor the Cannabis Administration and Opportunity Act in the Senate. We urged Congress to oppose the Combating Xylazine Act(H.R. 1266/S. 545), Nitazene Control Act (H.R. 5415 /S. 3076), and STOP Nitazenes Act (H.R. 7970).
We urged Congress to support and co-sponsor the MORE Act (H.R. 5068). We urged Congress to oppose the Combating Xylazine Act(H.R. 1266/S. 545), Nitazene Control Act (H.R. 5415 /S. 3076), and STOP Nitazenes Act (H.R. 7970).
We urged Congress to co-sponsor the MORE Act (119th Congress - H.R. 5068).
We led a coalition to oppose passage of the HALT Fentanyl Act(H.R. 27 / S. 331) in Congress. We urged Congress to re-introduce the MORE Act (118th Congress - H.R. 5601).
We led a coalition to oppose passage of the HALT Fentanyl Act(H.R. 27 / S. 331) in Congress. We urged Congress to re-introduce the MORE Act (118th Congress - H.R. 5601).
We led a coalition to oppose passage of the HALT Fentanyl Act(H.R. 27 / S. 331) in Congress. We urged Congress to re-introduce the MORE Act (118th Congress - H.R. 5601).
We urged Congress to co-sponsor the MORE Act (118th Congress - H.R. 5601).
We led a coalition to oppose passage of the HALT Fentanyl Act(H.R. 27 / S. 331) in Congress. We urged Congress to re-introduce the MORE Act (118th Congress - H.R. 5601).
A bill to make 1 percent across-the-board rescissions in non-defense, non-homeland-security, and non-veterans-affairs discretionary spending for each of fiscal years 2024 and 2025.
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
We led a coalition to oppose passage of the HALT Fentanyl Act(H.R. 27 / S. 331) in Congress. We urged Congress to re-introduce the MORE Act (118th Congress - H.R. 5601).
A bill to make 1 percent across-the-board rescissions in non-defense, non-homeland-security, and non-veterans-affairs discretionary spending for each of fiscal years 2024 and 2025.
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
We led a coalition to oppose passage of the HALT Fentanyl Act(H.R. 27 / S. 331) in Congress. We urged Congress to re-introduce the MORE Act (118th Congress - H.R. 5601).
Opposition to inclusion of the Combating Xylazine Act (H.R. 1839/S. 993) in the SUPPORT Act reauthorization (H.R. 4531).
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753); Opposing the Combating Xylazine Act (H.R. 1839/S. 993); Supporting passage of the MORE Act (H.R. 5601) and the Cannabis Administration and Opportunity Act (S. 4226)
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753); Opposing the Combating Xylazine Act (H.R. 1839/S. 993); Supporting passage of the MORE Act (H.R. 5601) and the Cannabis Administration and Opportunity Act (S. 4226)
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753); Opposing the Combating Xylazine Act (H.R. 1839/S. 993); Supporting passage of the MORE Act (H.R. 5601) and the Cannabis Administration and Opportunity Act (S. 4226)
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753); Opposing the Combating Xylazine Act (H.R. 1839/S. 993); Supporting passage of the MORE Act (H.R. 5601) and the Cannabis Administration and Opportunity Act (S. 4226)
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753); Opposing the Combating Xylazine Act (H.R. 1839/S. 993); Supporting passage of the MORE Act (H.R. 5601) and the Cannabis Administration and Opportunity Act (S. 4226)
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753).
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753); Opposing the Combating Xylazine Act (H.R. 1839/S. 993); Supporting passage of the MORE Act (H.R. 5601) and the Cannabis Administration and Opportunity Act (S. 4226)
Support for Patients and Communities Reauthorization Act
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Opposition to inclusion of the Combating Xylazine Act (H.R. 1839/S. 993) in the SUPPORT Act reauthorization (H.R. 4531).
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753); Opposing the Combating Xylazine Act (H.R. 1839/S. 993); Supporting passage of the MORE Act (H.R. 5601) and the Cannabis Administration and Opportunity Act (S. 4226)
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753).
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753); Opposing the Combating Xylazine Act (H.R. 1839/S. 993); Supporting passage of the MORE Act (H.R. 5601) and the Cannabis Administration and Opportunity Act (S. 4226)
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753); Opposing the Combating Xylazine Act (H.R. 1839/S. 993); Supporting passage of the MORE Act (H.R. 5601) and the Cannabis Administration and Opportunity Act (S. 4226)
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753); Opposing the Combating Xylazine Act (H.R. 1839/S. 993); Supporting passage of the MORE Act (H.R. 5601) and the Cannabis Administration and Opportunity Act (S. 4226)
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753); Opposing the Combating Xylazine Act (H.R. 1839/S. 993); Supporting passage of the MORE Act (H.R. 5601) and the Cannabis Administration and Opportunity Act (S. 4226)
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753); Opposing the Combating Xylazine Act (H.R. 1839/S. 993); Supporting passage of the MORE Act (H.R. 5601) and the Cannabis Administration and Opportunity Act (S. 4226)
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753); Opposing the Combating Xylazine Act (H.R. 1839/S. 993); Supporting passage of the MORE Act (H.R. 5601) and the Cannabis Administration and Opportunity Act (S. 4226)
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753); Opposing the Combating Xylazine Act (H.R. 1839/S. 993); Supporting passage of the MORE Act (H.R. 5601) and the Cannabis Administration and Opportunity Act (S. 4226)
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753).
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753); Opposing the Combating Xylazine Act (H.R. 1839/S. 993); Supporting passage of the MORE Act (H.R. 5601) and the Cannabis Administration and Opportunity Act (S. 4226)
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753); Opposing the Combating Xylazine Act (H.R. 1839/S. 993); Supporting passage of the MORE Act (H.R. 5601) and the Cannabis Administration and Opportunity Act (S. 4226)
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753); Opposing the Combating Xylazine Act (H.R. 1839/S. 993); Supporting passage of the MORE Act (H.R. 5601) and the Cannabis Administration and Opportunity Act (S. 4226)
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753); Opposing the Combating Xylazine Act (H.R. 1839/S. 993); Supporting passage of the MORE Act (H.R. 5601) and the Cannabis Administration and Opportunity Act (S. 4226)
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753).
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753); Opposing the Combating Xylazine Act (H.R. 1839/S. 993); Supporting passage of the MORE Act (H.R. 5601) and the Cannabis Administration and Opportunity Act (S. 4226)
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753); Opposing the Combating Xylazine Act (H.R. 1839/S. 993); Supporting passage of the MORE Act (H.R. 5601) and the Cannabis Administration and Opportunity Act (S. 4226)
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753).
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753); Opposing the Combating Xylazine Act (H.R. 1839/S. 993); Supporting passage of the MORE Act (H.R. 5601) and the Cannabis Administration and Opportunity Act (S. 4226)
Cannabis Administration and Opportunity Act
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753); Opposing the Combating Xylazine Act (H.R. 1839/S. 993); Supporting passage of the MORE Act (H.R. 5601) and the Cannabis Administration and Opportunity Act (S. 4226)
Cannabis Administration and Opportunity Act
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753); Opposing the Combating Xylazine Act (H.R. 1839/S. 993); Supporting passage of the MORE Act (H.R. 5601) and the Cannabis Administration and Opportunity Act (S. 4226)
Cannabis Administration and Opportunity Act
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753); Opposing the Combating Xylazine Act (H.R. 1839/S. 993); Supporting passage of the MORE Act (H.R. 5601) and the Cannabis Administration and Opportunity Act (S. 4226)
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753); Opposing the Combating Xylazine Act (H.R. 1839/S. 993); Supporting passage of the MORE Act (H.R. 5601) and the Cannabis Administration and Opportunity Act (S. 4226)
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753); Opposing the Combating Xylazine Act (H.R. 1839/S. 993); Supporting passage of the MORE Act (H.R. 5601) and the Cannabis Administration and Opportunity Act (S. 4226)
Opposition to inclusion of the Combating Xylazine Act (H.R. 1839/S. 993) in the SUPPORT Act reauthorization (H.R. 4531).
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753); Opposing the Combating Xylazine Act (H.R. 1839/S. 993); Supporting passage of the MORE Act (H.R. 5601) and the Cannabis Administration and Opportunity Act (S. 4226)
Opposing inclusion of the Combating Xylazine Act (H.R. 1839/S. 993) in the SUPPORT Act reauthorization.
Opposition to inclusion of the Combating Xylazine Act (H.R. 1839/S. 993) in the SUPPORT Act reauthorization (H.R. 4531).
Opposing inclusion of the Combating Xylazine Act (H.R. 1839/S. 993) in the SUPPORT Act reauthorization.
Supported the introduction of the Reentry Act (H.R. 2400) in the House.
Children Don't Belong on Tobacco Farms Act
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Opposed passage of the HALT Fentanyl Act (H.R. 467); Supported the Drug Policy Reform Act (H.R. 4020)
Children Don't Belong on Tobacco Farms Act
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supported the Drug Policy Reform Act (H.R. 4020); Supporting reintroduction of the Cannabis Administration and Opportunity Act (CAOA) (S.4591)
Children Don't Belong on Tobacco Farms Act
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supported the Drug Policy Reform Act (H.R. 4020); Supporting reintroduction of the Cannabis Administration and Opportunity Act (CAOA) (S.4591)
Support for Patients and Communities Reauthorization Act
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Opposition to inclusion of the Combating Xylazine Act (H.R. 1839/S. 993) in the SUPPORT Act reauthorization (H.R. 4531).
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supported the Drug Policy Reform Act (H.R. 4020); Supporting reintroduction of the Cannabis Administration and Opportunity Act (CAOA) (S.4591)
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supported the Drug Policy Reform Act (H.R. 4020); Supporting reintroduction of the Cannabis Administration and Opportunity Act (CAOA) (S.4591)
Opposed passage of the HALT Fentanyl Act (H.R. 467); Supported the Drug Policy Reform Act (H.R. 4020)
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supported the Drug Policy Reform Act (H.R. 4020); Supporting reintroduction of the Cannabis Administration and Opportunity Act (CAOA) (S.4591)
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supported the Drug Policy Reform Act (H.R. 4020); Supporting reintroduction of the Cannabis Administration and Opportunity Act (CAOA) (S.4591)
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients
Opposing inclusion of the Combating Xylazine Act (H.R. 1839/S. 993) in the SUPPORT Act reauthorization.
Opposition to inclusion of the Combating Xylazine Act (H.R. 1839/S. 993) in the SUPPORT Act reauthorization (H.R. 4531).
Opposing inclusion of the Combating Xylazine Act (H.R. 1839/S. 993) in the SUPPORT Act reauthorization.
Cannabis Administration and Opportunity Act
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supported the Drug Policy Reform Act (H.R. 4020); Supporting reintroduction of the Cannabis Administration and Opportunity Act (CAOA) (S.4591)
Cannabis Administration and Opportunity Act
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supported the Drug Policy Reform Act (H.R. 4020); Supporting reintroduction of the Cannabis Administration and Opportunity Act (CAOA) (S.4591)
Mainstreaming Addiction Treatment Act of 2021
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Lobbied for $150 million appropriations funding for syringe service providers and to lift the federal ban on syringes. Supported passage of MAT Act (S.445/H.R. 1384) which expands access to medication for people who use drugs.
Mainstreaming Addiction Treatment Act of 2021
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Lobbied for appropriations funding for syringe service providers and to lift the federal ban on syringes. Supported passage of MAT Act (S.445/H.R. 1384) which expands access to medication for people who use drugs.
Mainstreaming Addiction Treatment Act of 2021
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Lobbied for $150 million appropriations funding for syringe service providers and to lift the federal ban on syringes. Supported passage of MAT Act (S.445/H.R. 1384) which expands access to medication for people who use drugs.
Mainstreaming Addiction Treatment Act of 2021
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Lobbied for $150 million appropriations funding for syringe service providers and to lift the federal ban on syringes. Supported passage of MAT Act (S.445/H.R. 1384) which expands access to medication for people who use drugs.
Lobbied for $69.5 million appropriations funding for syringe service providers and to lift the federal ban on syringes. Lobbying to pass a fentanyl harm reduction bill called the STOP Fentanyl Act (HR 2366/S 1457) which emphasizes expanding access to health services for people who use drugs.
Lobbied for $69.5 million appropriations funding for syringe service providers and to lift the federal ban on syringes. Lobbying to pass a fentanyl harm reduction bill called the STOP Fentanyl Act (HR 2366/S 1457) which emphasizes expanding access to health services for people who use drugs.
Marijuana Opportunity Reinvestment and Expungement Act
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Marijuana Opportunity Reinvestment and Expungement Act
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Marijuana Opportunity Reinvestment and Expungement Act
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Marijuana Opportunity Reinvestment and Expungement Act
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Marijuana Opportunity Reinvestment and Expungement Act
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions. Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Lobbied for $69.5 million appropriations funding for syringe service providers and to lift the federal ban on syringes. Lobbying to pass a fentanyl harm reduction bill called the STOP Fentanyl Act (HR 2366/S 1457) which emphasizes expanding access to health services for people who use drugs.
We urged Congress to support and co-sponsor the MORE Act (H.R. 5068). We urged Congress to support and co-sponsor the Cannabis Administration and Opportunity Act in the Senate. We urged Congress to oppose the Combating Xylazine Act(H.R. 1266/S. 545), Nitazene Control Act (H.R. 5415 /S. 3076), and STOP Nitazenes Act (H.R. 7970).
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2026 · first_quarter · Q1
We urged Congress to support and co-sponsor the MORE Act (H.R. 5068). We urged Congress to oppose the Combating Xylazine Act(H.R. 1266/S. 545), Nitazene Control Act (H.R. 5415 /S. 3076), and STOP Nitazenes Act (H.R. 7970).
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2025 · fourth_quarter · Q4
We urged Congress to co-sponsor the MORE Act (119th Congress - H.R. 5068).
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2025 · third_quarter · Q3
We urged Congress to co-sponsor the MORE Act (118th Congress - H.R. 5601).
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2025 · second_quarter · Q2
We led a coalition to oppose passage of the HALT Fentanyl Act(H.R. 27 / S. 331) in Congress. We urged Congress to re-introduce the MORE Act (118th Congress - H.R. 5601).
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2025 · first_quarter · Q1
We led a coalition to oppose passage of the HALT Fentanyl Act(H.R. 27 / S. 331) in Congress. We urged Congress to re-introduce the MORE Act (118th Congress - H.R. 5601).
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2024 · fourth_quarter · Q4
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753); Opposing the Combating Xylazine Act (H.R. 1839/S. 993); Supporting passage of the MORE Act (H.R. 5601) and the Cannabis Administration and Opportunity Act (S. 4226)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2024 · third_quarter · Q3
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753); Opposing the Combating Xylazine Act (H.R. 1839/S. 993); Supporting passage of the MORE Act (H.R. 5601) and the Cannabis Administration and Opportunity Act (S. 4226)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2024 · second_quarter · Q2
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753); Opposing the Combating Xylazine Act (H.R. 1839/S. 993); Supporting passage of the MORE Act (H.R. 5601) and the Cannabis Administration and Opportunity Act (S. 4226)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2024 · first_quarter · Q1
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients via the RESTORE Act (H.R. 3479/S. 1753).
Opposition to inclusion of the Combating Xylazine Act (H.R. 1839/S. 993) in the SUPPORT Act reauthorization (H.R. 4531).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2023 · fourth_quarter · Q4
Requesting $150 million in funding and report language for Syringe Services Programs (SSPs) in the Infectious Diseases and the Opioid Epidemic program at the Centers for Disease Control and Prevention (CDC) in the FY 2024 Labor, Health and Human Services, Education, and Related Agencies (LHHS) appropriations bill.
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supporting passage of the TEST Act (S. 1950); Supporting eliminating the drug felony ban for SNAP recipients
Opposition to inclusion of the Combating Xylazine Act (H.R. 1839/S. 993) in the SUPPORT Act reauthorization (H.R. 4531).
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2023 · third_quarter · Q3
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supported the Drug Policy Reform Act (H.R. 4020); Supporting reintroduction of the Cannabis Administration and Opportunity Act (CAOA) (S.4591)
Opposing inclusion of the Combating Xylazine Act (H.R. 1839/S. 993) in the SUPPORT Act reauthorization.
Requesting $150 million in funding and report language for Syringe Services Programs (SSPs) in the Infectious Diseases and the Opioid Epidemic program at the Centers for Disease Control and Prevention (CDC) in the FY 2024 Labor, Health and Human Services, Education, and Related Agencies (LHHS) appropriations bill.
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2023 · second_quarter · Q2
Requesting $150 million in funding and report language for Syringe Services Programs (SSPs) in the Infectious Diseases and the Opioid Epidemic program at the Centers for Disease Control and Prevention (CDC) in the FY 2024 Labor, Health and Human Services, Education, and Related Agencies (LHHS) appropriations bill.
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supported the Drug Policy Reform Act (H.R. 4020); Supporting reintroduction of the Cannabis Administration and Opportunity Act (CAOA) (S.4591)
Opposing inclusion of the Combating Xylazine Act (H.R. 1839/S. 993) in the SUPPORT Act reauthorization.
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2023 · first_quarter · Q1
Requesting $150 million in funding and report language for Syringe Services Programs (SSPs) in the Infectious Diseases and the Opioid Epidemic program at the Centers for Disease Control and Prevention (CDC) in the FY 2024 Labor, Health and Human Services, Education, and Related Agencies (LHHS) appropriations bill.
Opposed passage of the HALT Fentanyl Act (H.R. 467); Supported the Drug Policy Reform Act (H.R. 4020)
Supported the introduction of the Reentry Act (H.R. 2400) in the House.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2022 · second_quarter · 2A
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Lobbied for $69.5 million appropriations funding for syringe service providers and to lift the federal ban on syringes. Lobbying to pass a fentanyl harm reduction bill called the STOP Fentanyl Act (HR 2366/S 1457) which emphasizes expanding access to health services for people who use drugs.
Lobbied for $69.5 million in appropriations for syringe service programs and other harm reduction tools/services.
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2022 · fourth_quarter · Q4
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions. Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Lobbied for appropriations funding for syringe service providers and to lift the federal ban on syringes. Supported passage of MAT Act (S.445/H.R. 1384) which expands access to medication for people who use drugs.
Lobbied for $150 million in appropriations for syringe service programs and other harm reduction tools/services. Lobbied for the MEAL Act to lift the ban on people with drug convictions receiving SNAP/TANF benefits.
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2022 · third_quarter · 3A
Lobbied for $150 million appropriations funding for syringe service providers and to lift the federal ban on syringes. Supported passage of MAT Act (S.445/H.R. 1384) which expands access to medication for people who use drugs.
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Lobbied for $150 million in appropriations for syringe service programs and other harm reduction tools/services. Lobbied for the MEAL Act to lift the ban on people with drug convictions receiving SNAP/TANF benefits.
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2022 · third_quarter · Q3
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Lobbied for $150 million in appropriations for syringe service programs and other harm reduction tools/services.
Lobbied for $150 million appropriations funding for syringe service providers and to lift the federal ban on syringes. Supported passage of MAT Act (S.445/H.R. 1384) which expands access to medication for people who use drugs.
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2022 · second_quarter · Q2
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Lobbied for $150 million appropriations funding for syringe service providers and to lift the federal ban on syringes. Supported passage of MAT Act (S.445/H.R. 1384) which expands access to medication for people who use drugs.
Lobbied for $150 million in appropriations for syringe service programs and other harm reduction tools/services.
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2022 · first_quarter · Q1
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Lobbied for $69.5 million appropriations funding for syringe service providers and to lift the federal ban on syringes. Lobbying to pass a fentanyl harm reduction bill called the STOP Fentanyl Act (HR 2366/S 1457) which emphasizes expanding access to health services for people who use drugs.
Lobbied for $69.5 million in appropriations for syringe service programs and other harm reduction tools/services.
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2021 · fourth_quarter · Q4
Lobbied for $69.5 million in appropriations for syringe service programs and other harm reduction tools/services.
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Lobbied for $69.5 million appropriations funding for syringe service providers and to lift the federal ban on syringes. Lobbying to pass a fentanyl harm reduction bill called the STOP Fentanyl Act (HR 2366/S 1457) which emphasizes expanding access to health services for people who use drugs.
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2021 · third_quarter · Q3
Lobbied for $120 million in appropriations for syringe service programs and other harm reduction tools/services.
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Lobbied for $120 million appropriations funding for syringe service providers and to lift the federal ban on syringes. Lobbying to pass a fentanyl harm reduction bill called the STOP Fentanyl Act (HR 2366/S 1457) which emphasizes expanding access to health services for people who use drugs.
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2021 · second_quarter · Q2
Lobbied the Senate to make improvements to the Justice in Policing Act (HR 1280), a federal policing bill. Lobbied on behalf of the FAIR Act(HR 2857) to end civil asset forfeiture. Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Lobbied for $120 million in appropriations for syringe service programs and other harm reduction tools/services.
Lobbied for $120 million appropriations funding for syringe service providers and to lift the federal ban on syringes. Lobbying to pass a fentanyl harm reduction bill called the STOP Fentanyl Act (HR 2366/S 1457) which emphasizes expanding access to health services for people who use drugs.
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2021 · first_quarter · Q1
Lobbied for $120 million in appropriations for syringe service programs and other harm reduction tools/services.
Lobbied to improving Justice in Policing Act, a federal policing bill. Supported sentencing reform bills. Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions.
Lobbied for $120 million appropriations funding for syringe service providers and to lift the federal ban on syringes.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2020 · fourth_quarter · Q4
Sentencing and criminal justice reform, fentanyl sentencing legislation, restoration of Pell Grants for incarcerated students and removal of barriers to financial aid for individuals with criminal convictions, marijuana reform. S 1622, the Stopping Overdoses of Fentanyl Analogues Act; S. 2701, Federal Initiative to Guarantee Health by Targeting Fentanyl Act; HR 3884, Marijuana Opportunity Reinvestment and Expungement Act. Supported efforts to release vulnerable individuals from incarcerated settings.
Advocated for funding harm reduction services in the Congressional budget in light of COVID-19 and high overdose rates.
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2020 · third_quarter · Q3
Sentencing and criminal justice reform, fentanyl sentencing legislation, restoration of Pell Grants for incarcerated students and removal of barriers to financial aid for individuals with criminal convictions, marijuana reform. S 1622, the Stopping Overdoses of Fentanyl Analogues Act; S. 2701, Federal Initiative to Guarantee Health by Targeting Fentanyl Act; HR 3884, Marijuana Opportunity Reinvestment and Expungement Act. Supported efforts to release vulnerable individuals from incarcerated settings.
Drug overdose prevention, expanding access to drug treatment and harm reduction services. HR 2482/S 2074, the Medication Assisted Treatment Act; HR 2569/S 1365, Comprehensive Addiction Resources Emergency Act.
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2020 · second_quarter · Q2
Drug overdose prevention, expanding access to drug treatment and harm reduction services. HR 2482/S 2074, the Medication Assisted Treatment Act; HR 2569/S 1365, Comprehensive Addiction Resources Emergency Act. Supported efforts to release vulnerable individuals from incarcerated settings.
Sentencing and criminal justice reform, fentanyl sentencing legislation, restoration of Pell Grants for incarcerated students and removal of barriers to financial aid for individuals with criminal convictions, marijuana reform. S 1622, the Stopping Overdoses of Fentanyl Analogues Act; S. 2701, Federal Initiative to Guarantee Health by Targeting Fentanyl Act; HR 3884, Marijuana Opportunity Reinvestment and Expungement Act
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2020 · first_quarter · Q1
Sentencing and criminal justice reform, fentanyl sentencing legislation, restoration of Pell Grants for incarcerated students and removal of barriers to financial aid for individuals with criminal convictions, marijuana reform. S 1622, the Stopping Overdoses of Fentanyl Analogues Act; S. 2701, Federal Initiative to Guarantee Health by Targeting Fentanyl Act; HR 3884, Marijuana Opportunity Reinvestment and Expungement Act
Funding for medication assisted treatment in jails and prisons; removal of a congressional rider barring Washington DC from taxing and regulating marijuana.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Drug overdose prevention, expanding access to drug treatment and harm reduction services. HR 2482/S 2074, the Medication Assisted Treatment Act; HR 2569/S 1365, Comprehensive Addiction Resources Emergency Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Advocated for funding harm reduction services in the Congressional budget in light of COVID-19 and high overdose rates.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Funding for medication assisted treatment in jails and prisons; removal of a congressional rider barring Washington DC from taxing and regulating marijuana.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE